What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Gene
- Disease
Her scientific interests lie mostly in Autosomal dominant polycystic kidney disease, Internal medicine, Endocrinology, Renal function and Urology.
Her studies deal with areas such as Kidney disease and Polycystic kidney disease as well as Autosomal dominant polycystic kidney disease.
Her Internal medicine research focuses on Blood pressure and PKD1.
In her research on the topic of Blood pressure, Left ventricular hypertrophy is strongly related with Cardiology.
Her Renal function research includes themes of Creatinine, Body surface area and Kidney.
Her Urology study incorporates themes from Tolvaptan, Confidence interval and Albuminuria.
Her most cited work include:
- Tolvaptan in patients with autosomal dominant polycystic kidney disease (833 citations)
- Volume Progression in Polycystic Kidney Disease (541 citations)
- The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. (314 citations)
What are the main themes of her work throughout her whole career to date?
The scientist’s investigation covers issues in Internal medicine, Autosomal dominant polycystic kidney disease, Endocrinology, Blood pressure and Renal function.
Arlene B. Chapman has included themes like Pharmacogenetics and Cardiology in her Internal medicine study.
Her study in Autosomal dominant polycystic kidney disease is interdisciplinary in nature, drawing from both Urology, Kidney disease and Polycystic kidney disease.
Her Urology course of study focuses on Tolvaptan and Placebo.
Her Blood pressure study frequently draws connections between related disciplines such as Pharmacology.
Her research investigates the connection between Renal function and topics such as Clinical trial that intersect with issues in Intensive care medicine.
She most often published in these fields:
- Internal medicine (59.37%)
- Autosomal dominant polycystic kidney disease (45.08%)
- Endocrinology (40.95%)
What were the highlights of her more recent work (between 2018-2021)?
- Autosomal dominant polycystic kidney disease (45.08%)
- Internal medicine (59.37%)
- Urology (20.95%)
In recent papers she was focusing on the following fields of study:
Her main research concerns Autosomal dominant polycystic kidney disease, Internal medicine, Urology, Kidney disease and Blood pressure.
The various areas that Arlene B. Chapman examines in her Autosomal dominant polycystic kidney disease study include Tolvaptan, Renal function and Polycystic kidney disease.
As a part of the same scientific family, she mostly works in the field of Internal medicine, focusing on Endocrinology and, on occasion, Reactive oxygen species.
Her studies in Urology integrate themes in fields like Urine and Urinary system.
Her work carried out in the field of Kidney disease brings together such families of science as Bioinformatics, Nephropathy, Disease, End stage renal disease and Family history.
The Blood pressure study combines topics in areas such as Beta blocker and Metoprolol.
Between 2018 and 2021, her most popular works were:
- Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease. (16 citations)
- Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease (14 citations)
- Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease. (11 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Disease
Her primary areas of study are Autosomal dominant polycystic kidney disease, Polycystic kidney disease, Urology, Kidney Volume and Kidney disease.
Autosomal dominant polycystic kidney disease is a primary field of her research addressed under Cyst.
Her research investigates the connection between Polycystic kidney disease and topics such as Renal function that intersect with problems in Creatinine.
Her Urology research includes themes of Plasma renin activity, Hydrochlorothiazide, Candesartan, Chlorthalidone and Receiver operating characteristic.
Her Kidney Volume research is multidisciplinary, relying on both Stage, Disease progression, Egfr decline and Cystic disease.
Her research integrates issues of Alport syndrome, Nephropathy and End stage renal disease in her study of Kidney disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
